Detail page

Knowledge Web

Person

Begüm Irmak Ön

Ärztin

Name	Begüm Irmak Ön
Time	2023- (Wirkungsdaten)
Place	Istanbul-Üsküdar (Geburtsort) München (Wirkungsort) Deutschland
Gender	weiblich
Academic degree	Dr. (Ludwig-Maximilians-Universität München, Medizinische Fakultät) (2023)
Profession	Ärztin
Variant	Begüm Ön Begum Irmak On
Related	Ludwig-Maximilians-Universität München. Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie
Source	ResearchGate: https://www.researchgate.net/profile/Begum-Irmak-On (Stand: 20.01.2025) https://www.ibe.med.uni-muenchen.de/mitarbeiter/mitarbeiter/oen/index.html (Stand: 20.01.2025)
Record type	Person
GND-Identifier	1316079945
Record ID	1316079945
Involved in show all The validation of prediction models deserves more recognition Prognostic models in multiple sclerosis: progress and challenges in clinical integration Framework for personalized prediction of treatment response in relapsing-remitting multiple sclerosis: a replication study in independent data Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis Prediction of prognosis and response to fingolimod in people with relapsing-remitting multiple sclerosis Antidepressant use and stroke or mortality risk in the elderly

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Begüm Irmak Ön

The validation of prediction models deserves more recognition

Prognostic models in multiple sclerosis: progress and challenges in clinical integration

Framework for personalized prediction of treatment response in relapsing-remitting multiple sclerosis: a replication study in independent data

Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis

Prediction of prognosis and response to fingolimod in people with relapsing-remitting multiple sclerosis

Antidepressant use and stroke or mortality risk in the elderly